LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?

被引:1
|
作者
Kim, Mi Kyoung [1 ]
Seong, Seok Ju [1 ]
机构
[1] CHA Univ, CHA Gangnam Med Ctr, Dept Obstet & Gynecol, Seoul 135913, South Korea
关键词
INTRAUTERINE SYSTEM; MANAGEMENT;
D O I
10.3802/jgo.2013.24.2.103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:103 / 104
页数:2
相关论文
共 38 条
  • [1] LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
    Abu Hashim, Hatem
    Zayed, Abdelhady
    Ghayaty, Essam
    El Rakhawy, Mohamed
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (02) : 128 - 134
  • [2] Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
    Dore, Molly
    Filoche, Sara
    Danielson, Kirsty
    Henry, Claire
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 36
  • [3] Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study
    Prip, Clara M.
    Stentebjerg, Maria
    Bennetsen, Mary H.
    Petersen, Lone K.
    Bor, Pinar
    [J]. PLOS ONE, 2022, 17 (04):
  • [4] The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia - A long-term follow-up study
    Varma, Rajesh
    Soneja, Hemi
    Bhatia, Kalsang
    Ganesan, Raji
    Rollason, Terence
    Clark, T. Justin
    Gupta, Janesh K.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 139 (02) : 169 - 175
  • [5] Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study
    Scarselli, Gianfranco
    Bargelli, Gianni
    Taddei, Gian Luigi
    Marchionni, Mauro
    Peruzzi, Elena
    Pieralli, Annalisa
    Mattei, Alberto
    Buccoliero, Anna Maria
    Fambrini, Massimiliano
    [J]. FERTILITY AND STERILITY, 2011, 95 (01) : 420 - 422
  • [6] Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling
    Rotenberg, O.
    Fridman, D.
    Doulaveris, G.
    Renz, M.
    Kaplan, J.
    Gebb, J.
    Xie, X.
    Goldberg, G. L.
    Dar, P.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (04) : 546 - 551
  • [7] LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia
    Fang, Fang
    Xu, Hao
    Wu, Ling
    Hu, Linyi
    Liu, Ying
    Li, Yinnan
    Zhang, Chunhua
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5412 - 5419
  • [8] Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long.-term follow-up
    Wildemeersch, D.
    Janssens, D.
    Pylyser, K.
    De Weverc, N.
    Verbeeck, G.
    Dhont, M.
    Tjalma, W.
    [J]. MATURITAS, 2007, 57 (02) : 210 - 213
  • [9] The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
    Chen, Xiaojun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)
  • [10] Levonorgestril Intrauterine System (LNG-IUS) Versus Medroxyprogesterone Acetate for the Treatment of Endometrial Hyperplasia: A Randomized Control Trial
    Rizvi, Sarwat
    Ghaffar, Shanza
    Haider, Rubar
    Jafri, Anum
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 675 - 678